Cargando…
An economic analysis of patient controlled remifentanil and epidural analgesia as pain relief in labour (RAVEL trial); a randomised controlled trial
OBJECTIVE: To compare the costs of a strategy of patient controlled remifentanil versus epidural analgesia for pain relief in labour. DESIGN: We performed a multicentre randomised controlled trial in 15 hospitals in the Netherlands, the RAVEL trial. Costs were analysed from a health care perspective...
Autores principales: | , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6181333/ https://www.ncbi.nlm.nih.gov/pubmed/30307986 http://dx.doi.org/10.1371/journal.pone.0205220 |
_version_ | 1783362375396622336 |
---|---|
author | Freeman, Liv Middeldorp, Johanna van den Akker, Eline Oudijk, Martijn Bax, Caroline van Huizen, Marloes Radder, Celine Fong, Bianca Bloemenkamp, Kitty Dahan, Albert Struys, Michel Mol, Ben Willem van Lith, Jan van den Akker-van Marle, Elske |
author_facet | Freeman, Liv Middeldorp, Johanna van den Akker, Eline Oudijk, Martijn Bax, Caroline van Huizen, Marloes Radder, Celine Fong, Bianca Bloemenkamp, Kitty Dahan, Albert Struys, Michel Mol, Ben Willem van Lith, Jan van den Akker-van Marle, Elske |
author_sort | Freeman, Liv |
collection | PubMed |
description | OBJECTIVE: To compare the costs of a strategy of patient controlled remifentanil versus epidural analgesia for pain relief in labour. DESIGN: We performed a multicentre randomised controlled trial in 15 hospitals in the Netherlands, the RAVEL trial. Costs were analysed from a health care perspective alongside the RAVEL trial. POPULATION: Pregnant women of intermediate to high risk beyond 32 weeks gestation who planned vaginal delivery. METHODS: Women were randomised before the onset of labour, to receive either patient controlled remifentanil or epidural analgesia when pain relief was requested during labour. MAIN OUTCOME MEASURES: Primary outcome for effectiveness was satisfaction with pain relief, expressed as the area under the curve (AUC). A higher AUC represents higher satisfaction with pain relief. Here, we present an economic analysis from a health care perspective including costs from the start of labour to ten days postpartum. Health-care utilization was documented in the Case Report Forms and by administering an additional questionnaire. RESULTS: The costs in the patient controlled remifentanil group (n = 687) and in the epidural group (n = 671) were €2900 versus €3185 respectively (mean difference of -€282 (95% CI -€611 to €47)). The (non-significant) higher costs in the epidural analgesia group could be mainly attributed to higher costs of neonatal admission. CONCLUSION: From an economic perspective, there is no preferential pain treatment in labouring intermediate to high risk women. Since patient controlled remifentanil is not equivalent to epidural analgesia with respect to AUC for satisfaction with pain relief we recommend epidural analgesia as the method of choice. However, if appropriately counselled on effect and side effects there is, from an economic perspective, no reason to deny women patient controlled remifentanil. |
format | Online Article Text |
id | pubmed-6181333 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-61813332018-10-26 An economic analysis of patient controlled remifentanil and epidural analgesia as pain relief in labour (RAVEL trial); a randomised controlled trial Freeman, Liv Middeldorp, Johanna van den Akker, Eline Oudijk, Martijn Bax, Caroline van Huizen, Marloes Radder, Celine Fong, Bianca Bloemenkamp, Kitty Dahan, Albert Struys, Michel Mol, Ben Willem van Lith, Jan van den Akker-van Marle, Elske PLoS One Research Article OBJECTIVE: To compare the costs of a strategy of patient controlled remifentanil versus epidural analgesia for pain relief in labour. DESIGN: We performed a multicentre randomised controlled trial in 15 hospitals in the Netherlands, the RAVEL trial. Costs were analysed from a health care perspective alongside the RAVEL trial. POPULATION: Pregnant women of intermediate to high risk beyond 32 weeks gestation who planned vaginal delivery. METHODS: Women were randomised before the onset of labour, to receive either patient controlled remifentanil or epidural analgesia when pain relief was requested during labour. MAIN OUTCOME MEASURES: Primary outcome for effectiveness was satisfaction with pain relief, expressed as the area under the curve (AUC). A higher AUC represents higher satisfaction with pain relief. Here, we present an economic analysis from a health care perspective including costs from the start of labour to ten days postpartum. Health-care utilization was documented in the Case Report Forms and by administering an additional questionnaire. RESULTS: The costs in the patient controlled remifentanil group (n = 687) and in the epidural group (n = 671) were €2900 versus €3185 respectively (mean difference of -€282 (95% CI -€611 to €47)). The (non-significant) higher costs in the epidural analgesia group could be mainly attributed to higher costs of neonatal admission. CONCLUSION: From an economic perspective, there is no preferential pain treatment in labouring intermediate to high risk women. Since patient controlled remifentanil is not equivalent to epidural analgesia with respect to AUC for satisfaction with pain relief we recommend epidural analgesia as the method of choice. However, if appropriately counselled on effect and side effects there is, from an economic perspective, no reason to deny women patient controlled remifentanil. Public Library of Science 2018-10-11 /pmc/articles/PMC6181333/ /pubmed/30307986 http://dx.doi.org/10.1371/journal.pone.0205220 Text en © 2018 Freeman et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Research Article Freeman, Liv Middeldorp, Johanna van den Akker, Eline Oudijk, Martijn Bax, Caroline van Huizen, Marloes Radder, Celine Fong, Bianca Bloemenkamp, Kitty Dahan, Albert Struys, Michel Mol, Ben Willem van Lith, Jan van den Akker-van Marle, Elske An economic analysis of patient controlled remifentanil and epidural analgesia as pain relief in labour (RAVEL trial); a randomised controlled trial |
title | An economic analysis of patient controlled remifentanil and epidural analgesia as pain relief in labour (RAVEL trial); a randomised controlled trial |
title_full | An economic analysis of patient controlled remifentanil and epidural analgesia as pain relief in labour (RAVEL trial); a randomised controlled trial |
title_fullStr | An economic analysis of patient controlled remifentanil and epidural analgesia as pain relief in labour (RAVEL trial); a randomised controlled trial |
title_full_unstemmed | An economic analysis of patient controlled remifentanil and epidural analgesia as pain relief in labour (RAVEL trial); a randomised controlled trial |
title_short | An economic analysis of patient controlled remifentanil and epidural analgesia as pain relief in labour (RAVEL trial); a randomised controlled trial |
title_sort | economic analysis of patient controlled remifentanil and epidural analgesia as pain relief in labour (ravel trial); a randomised controlled trial |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6181333/ https://www.ncbi.nlm.nih.gov/pubmed/30307986 http://dx.doi.org/10.1371/journal.pone.0205220 |
work_keys_str_mv | AT freemanliv aneconomicanalysisofpatientcontrolledremifentanilandepiduralanalgesiaaspainreliefinlabourraveltrialarandomisedcontrolledtrial AT middeldorpjohanna aneconomicanalysisofpatientcontrolledremifentanilandepiduralanalgesiaaspainreliefinlabourraveltrialarandomisedcontrolledtrial AT vandenakkereline aneconomicanalysisofpatientcontrolledremifentanilandepiduralanalgesiaaspainreliefinlabourraveltrialarandomisedcontrolledtrial AT oudijkmartijn aneconomicanalysisofpatientcontrolledremifentanilandepiduralanalgesiaaspainreliefinlabourraveltrialarandomisedcontrolledtrial AT baxcaroline aneconomicanalysisofpatientcontrolledremifentanilandepiduralanalgesiaaspainreliefinlabourraveltrialarandomisedcontrolledtrial AT vanhuizenmarloes aneconomicanalysisofpatientcontrolledremifentanilandepiduralanalgesiaaspainreliefinlabourraveltrialarandomisedcontrolledtrial AT radderceline aneconomicanalysisofpatientcontrolledremifentanilandepiduralanalgesiaaspainreliefinlabourraveltrialarandomisedcontrolledtrial AT fongbianca aneconomicanalysisofpatientcontrolledremifentanilandepiduralanalgesiaaspainreliefinlabourraveltrialarandomisedcontrolledtrial AT bloemenkampkitty aneconomicanalysisofpatientcontrolledremifentanilandepiduralanalgesiaaspainreliefinlabourraveltrialarandomisedcontrolledtrial AT dahanalbert aneconomicanalysisofpatientcontrolledremifentanilandepiduralanalgesiaaspainreliefinlabourraveltrialarandomisedcontrolledtrial AT struysmichel aneconomicanalysisofpatientcontrolledremifentanilandepiduralanalgesiaaspainreliefinlabourraveltrialarandomisedcontrolledtrial AT molbenwillem aneconomicanalysisofpatientcontrolledremifentanilandepiduralanalgesiaaspainreliefinlabourraveltrialarandomisedcontrolledtrial AT vanlithjan aneconomicanalysisofpatientcontrolledremifentanilandepiduralanalgesiaaspainreliefinlabourraveltrialarandomisedcontrolledtrial AT vandenakkervanmarleelske aneconomicanalysisofpatientcontrolledremifentanilandepiduralanalgesiaaspainreliefinlabourraveltrialarandomisedcontrolledtrial AT freemanliv economicanalysisofpatientcontrolledremifentanilandepiduralanalgesiaaspainreliefinlabourraveltrialarandomisedcontrolledtrial AT middeldorpjohanna economicanalysisofpatientcontrolledremifentanilandepiduralanalgesiaaspainreliefinlabourraveltrialarandomisedcontrolledtrial AT vandenakkereline economicanalysisofpatientcontrolledremifentanilandepiduralanalgesiaaspainreliefinlabourraveltrialarandomisedcontrolledtrial AT oudijkmartijn economicanalysisofpatientcontrolledremifentanilandepiduralanalgesiaaspainreliefinlabourraveltrialarandomisedcontrolledtrial AT baxcaroline economicanalysisofpatientcontrolledremifentanilandepiduralanalgesiaaspainreliefinlabourraveltrialarandomisedcontrolledtrial AT vanhuizenmarloes economicanalysisofpatientcontrolledremifentanilandepiduralanalgesiaaspainreliefinlabourraveltrialarandomisedcontrolledtrial AT radderceline economicanalysisofpatientcontrolledremifentanilandepiduralanalgesiaaspainreliefinlabourraveltrialarandomisedcontrolledtrial AT fongbianca economicanalysisofpatientcontrolledremifentanilandepiduralanalgesiaaspainreliefinlabourraveltrialarandomisedcontrolledtrial AT bloemenkampkitty economicanalysisofpatientcontrolledremifentanilandepiduralanalgesiaaspainreliefinlabourraveltrialarandomisedcontrolledtrial AT dahanalbert economicanalysisofpatientcontrolledremifentanilandepiduralanalgesiaaspainreliefinlabourraveltrialarandomisedcontrolledtrial AT struysmichel economicanalysisofpatientcontrolledremifentanilandepiduralanalgesiaaspainreliefinlabourraveltrialarandomisedcontrolledtrial AT molbenwillem economicanalysisofpatientcontrolledremifentanilandepiduralanalgesiaaspainreliefinlabourraveltrialarandomisedcontrolledtrial AT vanlithjan economicanalysisofpatientcontrolledremifentanilandepiduralanalgesiaaspainreliefinlabourraveltrialarandomisedcontrolledtrial AT vandenakkervanmarleelske economicanalysisofpatientcontrolledremifentanilandepiduralanalgesiaaspainreliefinlabourraveltrialarandomisedcontrolledtrial |